Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternating Carboplatin/Taxol and Carboplatin/Gemcitabine in Advanced NSCLC
NCT00259675Phase 2Completed
- Sponsor
- University of Saskatchewan
- Start
- May 2004
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, paclitaxel, gemcitabine in non-small cell lung cancer (NSCLC), sponsored by University of Saskatchewan. Started May 2004; status: completed.
02
Drugs
carboplatinpaclitaxelgemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00259675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259675.